GLRA1 Gene Hyperekplexia Genetic Test
At DNA Labs UAE, we offer the GLRA1 Gene Hyperekplexia Genetic Test for individuals suspected of having this rare genetic disorder. Hyperekplexia, also known as startle disease, is a neurological disorder characterized by an exaggerated startle reflex, muscle stiffness, and temporary paralysis following a startling stimulus.
Test Components and Price
The GLRA1 Gene Hyperekplexia Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Method
After the sample is collected, the report will be delivered within 3 to 4 weeks. The test utilizes NGS (Next-Generation Sequencing) technology to analyze the GLRA1 gene for mutations or variations.
Test Type and Doctor
The GLRA1 Gene Hyperekplexia Genetic Test falls under the category of Neurological Disorders. It is recommended to consult with a Neurologist for this test.
Test Department and Pre Test Information
The GLRA1 Gene Hyperekplexia Genetic Test is conducted in the Genetics department. Before the test, it is important to provide the clinical history of the patient and undergo a Genetic Counselling session to draw a pedigree chart of family members affected with GLRA1 Gene Hyperekplexia.
Test Details
The GLRA1 gene is associated with the rare genetic disorder hyperekplexia. It codes for the alpha-1 subunit of the glycine receptor in the brain and spinal cord. NGS genetic testing allows for the analysis of multiple genes simultaneously, providing a comprehensive evaluation of genetic variations associated with hyperekplexia.
NGS genetic testing for GLRA1 gene mutations can help diagnose hyperekplexia and identify the specific genetic variant causing the condition. This information is crucial for genetic counseling and determining the risk of passing the disorder on to future generations.
It is important to note that genetic testing should be performed by a qualified healthcare professional, such as a geneticist or genetic counselor, who can interpret the results and provide appropriate recommendations and support.
Test Name | GLRA1 Gene Hyperekplexia Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for GLRA1 Gene Hyperekplexia NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GLRA1 Gene Hyperekplexia |
Test Details |
The GLRA1 gene is associated with a rare genetic disorder called hyperekplexia, also known as startle disease. Hyperekplexia is a neurological disorder characterized by an exaggerated startle reflex, muscle stiffness, and temporary paralysis following a startling stimulus. It is typically caused by mutations in the GLRA1 gene, which codes for the alpha-1 subunit of the glycine receptor in the brain and spinal cord. NGS (Next-Generation Sequencing) genetic testing can be used to analyze the GLRA1 gene for mutations or variations. This type of testing allows for the simultaneous analysis of multiple genes, providing a comprehensive evaluation of genetic variations associated with hyperekplexia. NGS genetic testing for GLRA1 gene mutations can help diagnose hyperekplexia and identify the specific genetic variant causing the condition. This information is crucial for genetic counseling, as it can help determine the risk of passing the disorder on to future generations. It is important to note that genetic testing should be performed by a qualified healthcare professional, such as a geneticist or genetic counselor, who can interpret the results and provide appropriate recommendations and support. |